In vivo neurochemistry of primary focal hand dystonia: A magnetic resonance spectroscopic neurometabolite profiling study at 3T
- 26 October 2010
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 25 (16) , 2800-2808
- https://doi.org/10.1002/mds.23306
Abstract
The neurochemical basis of dystonia is unknown. The purpose of this study was to assess the differences of the inhibitory neurotransmitter, gamma amino butyric acid (GABA), in the sensorimotor cortex and the basal ganglia using magnetic resonance spectroscopy with optimized GABA sensitivity. Twenty‐two patients with focal hand dystonia and 22 healthy controls were studied. No significant differences in GABA were observed between the groups in either the sensorimotor cortex or in the basal ganglia. © Movement Disorder Society.Keywords
This publication has 31 references indexed in Scilit:
- A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coilMagnetic Resonance Imaging, 2007
- EPIDEMIOLOGY AND PATHOGENESISIntroduction to DystoniaPublished by Taylor & Francis ,2006
- The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transferJournal of Neurochemistry, 2006
- Selective homonuclear Hartmann–Hahn transfer method for in vivo spectral editing in the human brainMagnetic Resonance in Medicine, 2005
- Cramer-Rao bounds for parametric shape estimation in inverse problemsIEEE Transactions on Image Processing, 2003
- Impaired brain GABA in focal dystoniaAnnals of Neurology, 2001
- Automatic quantitation of localized in vivo1H spectra with LCModelNMR in Biomedicine, 2001
- Proton NMR chemical shifts and coupling constants for brain metabolitesNMR in Biomedicine, 2000
- Genetics of Primary DystoniaSeminars in Neurology, 1999
- Estimation of metabolite concentrations from localized in vivo proton NMR spectraMagnetic Resonance in Medicine, 1993